— AAPM&R calls for greater awareness of post-COVID cardiovascular complications among clinicians by Michael DePeau-Wilson Risks for cardiovascular complications, including pulmonary embolism, arterial and venous thromboses, myocardial infarction, and stroke, are...
As the pandemic ebbs, long-haul Covid still drains patients and confounds doctors
Researchers still don’t know precisely how many get long Covid, what causes it or how best to treat it By Eric Berger Many long haulers report fatigue, brain fog, and a range of other symptoms for months after their infection. Photograph: VioletaStoimenova/Getty...
In Long COVID, Blood Markers Are Linked to Neuropsychiatric Symptoms
In a new study of long COVID published March 13, 2022, in the Annals of Neurology, UC San Francisco researchers identified biomarkers present at elevated levels that may persist for many months in the blood of study participants who had long COVID with...
More than 1 in 5 adult Covid survivors in the U.S. may develop long Covid, a C.D.C. study suggests.
Researchers identified lasting health problems in many different organ systems, including the heart, lungs and kidneys. By Pam Belluck One in five adult Covid survivors under the age of 65 in the United States has experienced at least one health condition that could...
What We Know About Long Covid So Far
There is no universal definition of the complex condition, but clues about causes and potential treatments are beginning to emerge. By Knvul Sheikh and Pam Belluck Among the many confounding aspects of the coronavirus is the spectrum of possible symptoms, as well...
Over 75 percent of long Covid patients were not hospitalized for an initial illness, a study finds.
By Pam Belluck More than three-quarters of Americans diagnosed with long Covid were not sick enough to be hospitalized for their initial infection, a new analysis of tens of thousands of private insurance claims reported on Wednesday. The researchers...
Gut microbiota dynamics in a prospective cohort of patients with post-acute COVID-19 syndrome
By Qin Liu, et al. originally published January 26, 2022 in BMJ Gut. Abstract Background Long-term complications after COVID-19 are common, but the potential cause for persistent symptoms after viral clearance remains unclear. Objective To investigate...
A Randomised, Double-Blind, Placebo-Controlled Trial Evaluating Concentrated Phytochemical-Rich Nutritional Capsule in Addition to a Probiotic Capsule on Clinical Outcomes among Individuals with COVID-19—The UK Phyto-V Study
by Robert Thomas et al. Originally published March 16, 2022 Download PDF Browse Figures Citation Export Abstract Gut microflora dysbiosis affects the majority of individuals after COVID-19, contributing to both gastro-intestinal (GI) and non-GI symptoms. Natural...
‘Another Unequal Burden’: Working with Long Covid
Some research has shown that lingering Covid symptoms are more prevalent in people in their 30s and 40s — when workers are often in the prime of their careers. How will companies support employees with debilitating symptoms that can linger for months or even years...
Experts perplexed over number of people getting long COVID
BY JOSEPH CHOI Public health experts are divided over how many people are getting long COVID-19, a potentially debilitating condition that comes after a patient has recovered from the coronavirus. Ill effects from the condition can include fatigue, pain, neurological...
The Promising Treatment for Long COVID We’re Not Even Trying
Early anecdotes about Paxlovid’s effects on long COVID are intriguing, but no one’s testing them in clinical trials yet. By Katherine J. Wu In the two years since she caught the coronavirus, 38-year-old Jessica McGovern has cycled through “well over 100 drugs,...
‘I’ve had long Covid for two years now’
By James Gallagher Image caption,Neil Robinson has had long Covid for two years The initial emergency of Covid may feel like it's over, but thousands of people are still suffering from ongoing symptoms known as long Covid. So are we any closer to understanding the...
Low Dose Naltrexone Emerges as an Investigational Long COVID Therapeutic
By Stephen Ditmore Acute COVID-19 Clinical Trials There are four clinical trials of Low Dose Naltrexone (LDN) as an acute COVID-19 therapeutic in the United States, two of which are currently recruiting. Statera BioPharma (formerly Cytocom), which calls its...
USC-Affiliated Children’s Hospital Los Angeles to Begin Long COVID Study Under $8.3 Million NIH Grant
After the National Institutes of Health (NIH) awarded the USC-affiliated Children’s Hospital Los Angeles (CHLA) an $8.3 million grant in January, a team of experts is preparing to kick off a study to assess the long-term effects of COVID-19 (long COVID) in...
Memory, Concentration Problems Plague 70% of Long COVID Patients
— Cognitive tests show "notable reduction" in memory ability by Judy George Seven in 10 people, most of whom said they had long COVID, experienced concentration and memory problems months after acute SARS-CoV-2 infection and many performed worse than their peers on...